We are live on ! Find out more
HI

HBK Investments Portfolio holdings

AUM $9.85B
1-Year Est. Return 55.6%
This Fund
S&P 500
This Quarter Est. Return
+22.68%
1 Year Est. Return
+55.6%
3 Year Est. Return
+156.38%
5 Year Est. Return
+423.64%
10 Year Est. Return
+2,347.17%
AUM
$15.3B
AUM Growth
+$1.92B
Cap. Flow
-$855M
Cap. Flow %
-5.58%
Top 10 Hldgs %
58.72%
Holding
844
New
214
Increased
88
Reduced
167
Closed
165

Sector Composition

Rank Sector Weight
1 Technology 5.17%
2 Healthcare 2.88%
3 Consumer Discretionary 2.31%
4 Financials 2.07%
5 Industrials 0.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PGEN icon
626
PUT
Precigen
PGEN
$2.59B
$135K ﹤0.01%
13,200
-204,300
-94% -$1.32M
AGCWW
627
CALL
DELISTED
Altimeter Growth Corp Warrant
AGCWW
$129K ﹤0.01%
+23,750
New +$120K
TLRY icon
628
CALL
Tilray
TLRY
$622M
$124K ﹤0.01%
1,500
STLNW
629
CALL
Starling Oncology, Inc. Warrant
STLNW
$5.04M
$124K ﹤0.01%
63,499
IRWD icon
630
CALL
Ironwood Pharmaceuticals
IRWD
$714M
$120K ﹤0.01%
+10,500
New +$115K
KPLTW
631
CALL
DELISTED
Katapult Holdings Warrant
KPLTW
$105K ﹤0.01%
30,000
-120,000
-80% -$182K
PDAC.WS
632
CALL
DELISTED
Peridot Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordina
PDAC.WS
$105K ﹤0.01%
+59,059
New +$85.3K
STWOW
633
CALL
DELISTED
ACON S2 Acquisition Corp Warrant
STWOW
$97K ﹤0.01%
+59,106
New +$77K
MKTWW
634
CALL
DELISTED
MarketWise, Inc. Warrant
MKTWW
$86K ﹤0.01%
50,000
-136,100
-73% -$175K
RTP.WS
635
CALL
DELISTED
Reinvent Technology Partners Redeemable Warrants, each whole warrant exercisable for one Class A ord
RTP.WS
$86K ﹤0.01%
+26,582
New +$71.9K
ASTRW
636
CALL
DELISTED
Astra Space, Inc. Warrant
ASTRW
$66K ﹤0.01%
+50,000
New +$61.9K
HPX.WS
637
CALL
DELISTED
HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HPX.WS
$62K ﹤0.01%
58,192
-16,808
-22% -$14.8K
VYGG.WS
638
CALL
DELISTED
Vy Global Growth Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
VYGG.WS
$55K ﹤0.01%
+26,869
New +$48.7K
IPOF.WS
639
CALL
DELISTED
Social Capital Hedosophia Holdings Corp. VI Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
IPOF.WS
$46K ﹤0.01%
+14,158
New +$38.2K
ENPC.WS
640
CALL
DELISTED
Executive Network Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
ENPC.WS
$37K ﹤0.01%
+14,474
New +$38.7K
A icon
641
Agilent Technologies
A
$41.2B
-53,133
Closed -$5.36M
ABBV icon
642
AbbVie
ABBV
$435B
-12,923
Closed -$1.24M
ACEL icon
643
Accel Entertainment
ACEL
$987M
-50,000
Closed -$536K
ACR
644
ACRES Commercial Realty
ACR
$108M
-28,673
Closed -$180K
ADSK icon
645
Autodesk
ADSK
$52.6B
-9,768
Closed -$2.57M
ADT icon
646
ADT
ADT
$5.58B
-100,000
Closed -$817K
ADV icon
647
Advantage Solutions
ADV
$361M
-11,000
Closed -$2.79M
ALB icon
648
CALL
Albemarle
ALB
$15.5B
-34,300
Closed -$3.06M
ANSS
649
CALL
DELISTED
Ansys
ANSS
-5,500
Closed -$1.8M
ANSS
650
PUT
DELISTED
Ansys
ANSS
-5,500
Closed -$1.8M

Similar funds

HBK Investments's Q4 2020 Portfolio in Review

As of Q4 2020, HBK Investments held 844 positions worth $15.3B, up 14% from $13.4B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

HBK Investments withdrew a net $855M in Q4 2020, closing 165 positions and reducing 167 holdings. Its most notable exit was Immunomedics Inc, an estimated $553M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.2% of assets, up from 1.5% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, HBK Investments opened a new position in Slack Technologies, Inc. worth $607M.

  • HBK Investments's largest Q4 2020 buy was Slack Technologies, Inc.: 14,369,573 shares worth $607M.
  • HBK Investments added most to Maxim Integrated Products in Q4 2020, an estimated $287M increase.
  • HBK Investments's biggest Q4 2020 reduction was Broadcom, cutting an estimated $16.2M.
  • HBK Investments fully exited Immunomedics Inc in Q4 2020, selling an estimated $553M.
  • HBK Investments's ten largest holdings make up 59% of its $15.3B portfolio in Q4 2020.
  • HBK Investments opened 214 new positions and closed 165 in Q4 2020.
  • HBK Investments's portfolio value rose 14% quarter-over-quarter to $15.3B.

Based on HBK Investments's 13F filing for Q4 2020, filed 16 Feb 2021.